Moreover, we have demonstrated that the potassium channel protein KCa3.1 enhanced the tumor-initiating ability of LCSCs, which may be achieved by enhancing the glucose metabolism of LCSCs. The gene discussed is KCNQ5; the disease is neoplasm.